skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8830

A review on primary progressive aphasia

Review

(4116) Views  (923) Full article downloads

Authors: Gabriel C Léger, Nancy Johnson

Published Date January 2007 Volume 2007:3(6) Pages 745 - 752
DOI: http://dx.doi.org/10.2147/NDT.S1493

Gabriel C Léger1,2, Nancy Johnson3

1Neurology Service, Hôtel-Dieu du Centre Hospitalier de l’Univertité de Montréal, Montréal, Québec, Canada; 2Faculty of Medicine, Université de Montréal, Montréal, Québec, Canada; 3Cognitive Neurology and Alzheimer’s Disease Center, Department of Psychiatry and Behavioral Science, Northwestern University Feinberg School of Medicine, Chicago, IL, USA

Abstract: Primary progressive aphasia (PPA) is a neurodegenerative disease of insidious onset presenting with progressive isolated loss of language function, without significant impairment in other cognitive domains. Current diagnostic criteria require the language dysfunction to remain isolated for at least two years, and to remain the salient feature as the disease progresses, usually to involve other domains such as behavior, executive functions, and judgment. Although PPA in its early stages can usually be differentiated from probable Alzheimer’s disease (PRAD) and the behavioral variant of frontotemporal lobar degeneration by the absence of significant changes in memory and behavior, and the preservation of activities daily living, progression of the disease often leads to deficits more consistent with the latter. Underlying etiologies remain heterogeneous: the neuropathological characteristics associated with frontotemporal lobar degeneration, cortocobasal degeneration, and motor neuron disease are usually found. There is a strong genetic susceptibility with affliction of first-degree relatives with similar disease in up to 40 to 50% in some series. Pathogenic mutations in genes coding for the proteins tau and progranulin have been isolated. These are leading to a better understanding of the neuropathological mechanisms and hopefully targeted disease-modifying therapy. Current therapy is limited to improving mood symptoms and targeting behavior changes as they develop. Referral to specialized centers where speech therapy, counseling, and education for both patient and caregiver are available may be helpful.

Keywords: primary progressive aphasia








Readers of this article also read:

Periosteoplasty for covering gingival recessions: Clinical results
Refinement of rigid-body protein–protein docking using backbone and side-chain minimization with a coarse-grained model
Detection of retinal changes in Parkinson's disease with spectral-domain optical coherence tomography
Editorial
Diagnostic indicators for peptic ulcer perforation at a tertiary care hospital in Thailand
Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan
Comparison of generation 3 polyamidoamine dendrimer and generation 4 polypropylenimine dendrimer on drug loading, complex structure, release behavior, and cytotoxicity
Investigation of glucose-modified liposomes using polyethylene glycols with different chain lengths as the linkers for brain targeting
Helicobacter pylori infection and primary open-angle glaucoma: is there a connection?
Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant